Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
   C01 CARDIAC THERAPY
   C02 ANTIHYPERTENSIVES
   C03 DIURETICS
   C04 PERIPHERAL VASODILATORS
   C05 VASOPROTECTIVES
     C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
       C05AA Corticosteroids
         C05AA01 Hydrocortisone [DG:DG00012]
         C05AA04 Prednisolone [DG:DG00093]
         C05AA05 Betamethasone [DG:DG00095]
         C05AA06 Fluorometholone [DG:DG00294]
         C05AA08 Fluocortolone [DG:DG00295]
           D04218  Fluocortolone (USAN/INN)
           D04219  Fluocortolone caproate (USAN)
           D07973  Fluocortolone 21-pivalate
         C05AA09 Dexamethasone [DG:DG00011]
         C05AA10 Fluocinolone acetonide
         C05AA11 Fluocinonide
         C05AA12 Triamcinolone [DG:DG00010]
       C05AB Antibiotics
       C05AD Local anesthetics
       C05AE Muscle relaxants
       C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
     C05B ANTIVARICOSE THERAPY
     C05C CAPILLARY STABILIZING AGENTS
   C07 BETA BLOCKING AGENTS
   C08 CALCIUM CHANNEL BLOCKERS
   C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
   C10 LIPID MODIFYING AGENTS
 
 D DERMATOLOGICALS
   D01 ANTIFUNGALS FOR DERMATOLOGICAL USE
   D02 EMOLLIENTS AND PROTECTIVES
   D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
   D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D05 ANTIPSORIATICS
   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
   D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
     D07A CORTICOSTEROIDS, PLAIN
       D07AA Corticosteroids, weak (group I)
       D07AB Corticosteroids, moderately potent (group II)
       D07AC Corticosteroids, potent (group III)
         D07AC01 Betamethasone [DG:DG00095]
         D07AC02 Fluclorolone
         D07AC03 Desoximetasone
         D07AC04 Fluocinolone acetonide
         D07AC05 Fluocortolone [DG:DG00295]
           D04218  Fluocortolone (USAN/INN)
           D04219  Fluocortolone caproate (USAN)
           D07973  Fluocortolone 21-pivalate
         D07AC06 Diflucortolone [DG:DG00417]
         D07AC07 Fludroxycortide
         D07AC08 Fluocinonide
         D07AC09 Budesonide
         D07AC10 Diflorasone [DG:DG00418]
         D07AC11 Amcinonide
         D07AC12 Halometasone
         D07AC13 Mometasone [DG:DG00419]
         D07AC14 Methylprednisolone aceponate
         D07AC15 Beclometasone [DG:DG00097]
         D07AC16 Hydrocortisone aceponate
         D07AC17 Fluticasone [DG:DG00420]
         D07AC18 Prednicarbate
         D07AC19 Difluprednate
         D07AC21 Ulobetasol [DG:DG00421]
       D07AD Corticosteroids, very potent (group IV)
     D07B CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS
     D07C CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS
     D07X CORTICOSTEROIDS, OTHER COMBINATIONS
       D07XA Corticosteroids, weak, other combinations
       D07XB Corticosteroids, moderately potent, other combinations
       D07XC Corticosteroids, potent, other combinations
         D07XC01 Betamethasone [DG:DG00095]
         D07XC02 Desoximetasone
         D07XC03 Mometasone [DG:DG00419]
         D07XC04 Diflucortolone [DG:DG00417]
         D07XC05 Fluocortolone [DG:DG00295]
           D04218  Fluocortolone (USAN/INN)
           D04219  Fluocortolone caproate (USAN)
           D07973  Fluocortolone 21-pivalate
       D07XD Corticosteroids, very potent, other combinations
   D08 ANTISEPTICS AND DISINFECTANTS
   D09 MEDICATED DRESSINGS
   D10 ANTI-ACNE PREPARATIONS
   D11 OTHER DERMATOLOGICAL PREPARATIONS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
   H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
   H02 CORTICOSTEROIDS FOR SYSTEMIC USE
     H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
       H02AA Mineralocorticoids
       H02AB Glucocorticoids
         H02AB01 Betamethasone [DG:DG00095]
         H02AB02 Dexamethasone [DG:DG00011]
         H02AB03 Fluocortolone [DG:DG00295]
           D04218  Fluocortolone (USAN/INN)
           D04219  Fluocortolone caproate (USAN)
           D07973  Fluocortolone 21-pivalate
         H02AB04 Methylprednisolone [DG:DG00410]
         H02AB05 Paramethasone [DG:DG00508]
         H02AB06 Prednisolone [DG:DG00093]
         H02AB07 Prednisone [DG:DG00094]
         H02AB08 Triamcinolone [DG:DG00010]
         H02AB09 Hydrocortisone [DG:DG00012]
         H02AB10 Cortisone [DG:DG00509]
         H02AB11 Prednylidene
         H02AB12 Rimexolone
         H02AB13 Deflazacort
         H02AB14 Cloprednol
         H02AB15 Meprednisone
         H02AB17 Cortivazol
     H02B CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS
     H02C ANTIADRENAL PREPARATIONS
   H03 THYROID THERAPY
   H04 PANCREATIC HORMONES
   H05 CALCIUM HOMEOSTASIS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: November 2, 2020
According to WHO's ATC 2020

» Japanese version